<code id='4628CFE106'></code><style id='4628CFE106'></style>
    • <acronym id='4628CFE106'></acronym>
      <center id='4628CFE106'><center id='4628CFE106'><tfoot id='4628CFE106'></tfoot></center><abbr id='4628CFE106'><dir id='4628CFE106'><tfoot id='4628CFE106'></tfoot><noframes id='4628CFE106'>

    • <optgroup id='4628CFE106'><strike id='4628CFE106'><sup id='4628CFE106'></sup></strike><code id='4628CFE106'></code></optgroup>
        1. <b id='4628CFE106'><label id='4628CFE106'><select id='4628CFE106'><dt id='4628CFE106'><span id='4628CFE106'></span></dt></select></label></b><u id='4628CFE106'></u>
          <i id='4628CFE106'><strike id='4628CFE106'><tt id='4628CFE106'><pre id='4628CFE106'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:77641
          Adobe

          Private Medicare just isn’t the gold mine it once was. Case in point: Cano Health, a company once valued at $4.4 billion, is now bankrupt.

          The prospect of bankruptcy had stalked the Miami-based primary care provider for well over a year before its Chapter 11 filing on Sunday. A number of things had gone wrong. First, there was Cano’s rapid growth ahead of its 2021 initial public offering that gave way to a mountain of debt, currently sitting at $1.3 billion. Then there was public beef between its former directors and then-CEO.

          advertisement

          Most importantly, the company’s main business, Medicare Advantage, became less profitable. As evidence accumulated that the private insurers running MA plans game the system by exaggerating their members’ illnesses, the Biden administration vowed to fix the problem. This year, Medicare is phasing in a new payment model designed to reduce overpayment.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Akero's treatment for NASH falls short in cirrhosis study
          Akero's treatment for NASH falls short in cirrhosis study

          AdobeAkeroTherapeuticssaidTuesdaythatanexperimentalmedicinefailedtoshowasignificantbenefitforpatient

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Cardiologists urge adding sexual orientation, gender identity to health records

          AdobeTherearemoreopenlyLGBTQ+peopleintheU.S.thanever,butlittleisknownabouttheuniquehealthchallengest